Artículos por temáticas

Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease.

Joutsa J, Johansson J, Seppänen M, Noponen T, Kaasinen V.

J Nucl Med. 2015 Jul;56(7):1036-41. doi: 10.2967/jnumed.115.153734.

The wrong James Parkinson.

Stott SR.

Pract Neurol. 2015 Apr;15(2):148. doi: 10.1136/practneurol-2014-001043. No abstract available.

[Geriatric particularities of Parkinson's disease: Clinical and therapeutic aspects].

Belin J, Houéto JL, Constans T, Hommet C, de Toffol B, Mondon K.

Rev Neurol (Paris). 2015 Dec;171(12):841-52. doi: 10.1016/j.neurol.2015.08.002. Review. French.

LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.

Yang XY, Zhao EY, Zhuang WX, Sun FX, Han HL, Han HR, Lin ZJ, Pan ZF, Qu MH, Zeng XW, Ding Y.

Neurol Sci. 2015 Nov;36(11):2027-33. doi: 10.1007/s10072-015-2295-x.

A comparison of dance interventions in people with Parkinson disease and older adults.

McNeely ME, Duncan RP, Earhart GM.

Maturitas. 2015 May;81(1):10-6. doi: 10.1016/j.maturitas.2015.02.007. Review.

A nucleoprotein-enriched diet suppresses dopaminergic neuronal cell loss and motor deficit in mice with MPTP-induced Parkinson's disease.

Kiriyama K, Ohtaki H, Kobayashi N, Murai N, Matsumoto M, Sasaki S, Sawa C, Satoh K, Matsunaga M, Shioda S.

J Mol Neurosci. 2015 Mar;55(3):803-11. doi: 10.1007/s12031-014-0432-2.

Beta oscillations in freely moving Parkinson's subjects are attenuated during deep brain stimulation.

Quinn EJ, Blumenfeld Z, Velisar A, Koop MM, Shreve LA, Trager MH, Hill BC, Kilbane C, Henderson JM, Brontë-Stewart H.

Mov Disord. 2015 Nov;30(13):1750-8. doi: 10.1002/mds.26376.

Folic Acid Supplementation Ameliorates Oxidative Stress, Metabolic Functions and Developmental Anomalies in a Novel Fly Model of Parkinson's Disease.

Srivastav S, Singh SK, Yadav AK, Srikrishna S.

Neurochem Res. 2015 Jul;40(7):1350-9. doi: 10.1007/s11064-015-1598-x.

Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model.

Steinbeck JA, Choi SJ, Mrejeru A, Ganat Y, Deisseroth K, Sulzer D, Mosharov EV, Studer L.

Nat Biotechnol. 2015 Feb;33(2):204-9. doi: 10.1038/nbt.3124.

Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson's disease.

Liu LF, Song JX, Lu JH, Huang YY, Zeng Y, Chen LL, Durairajan SS, Han QB, Li M.

Sci Rep. 2015 Nov 18;5:16862. doi: 10.1038/srep16862.

α-Synuclein staging in the amygdala of a Parkinson's disease model: cell types involved.

Flores-Cuadrado A, Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A.

Eur J Neurosci. 2015 Jan;41(1):137-46. doi: 10.1111/ejn.12763.

What is the evidence to support home environmental adaptation in Parkinson's disease? A call for multidisciplinary interventions.

Bhidayasiri R, Jitkritsadakul O, Boonrod N, Sringean J, Calne SM, Hattori N, Hayashi A.

Parkinsonism Relat Disord. 2015 Oct;21(10):1127-32. doi: 10.1016/j.parkreldis.2015.08.025. Review.

A multi-centre, randomised controlled trial of the effectiveness of PDSAFE to prevent falls among people with Parkinson's: study protocol.

Goodwin VA, Pickering R, Ballinger C, Roberts H, McIntosh E, Lamb S, Nieuwboer A, Rochester L, Ashburn A; PDSAFE Protocol Development Group..

BMC Neurol. 2015 May 15;15:81. doi: 10.1186/s12883-015-0332-2.

Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.

Allen Reish HE, Standaert DG.

J Parkinsons Dis. 2015;5(1):1-19. doi: 10.3233/JPD-140491. Review.

[Camptocormia and Parkinson's disease: association or consequence?].

Frioui S, Jemni S.

Pan Afr Med J. 2015 Apr 9;20:339. doi: 10.11604/pamj.2015.20.339.6586. French. No abstract available.